Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)

NCT02402686 · clinicaltrials.gov ↗

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche